| Literature DB >> 29408951 |
Benedikt Hogan1,2, Daniel Eibach1, Ralf Krumkamp1,2, Nimako Sarpong2,3, Denise Dekker1,2, Benno Kreuels2,4, Oumou Maiga-Ascofaré1,2,3, Kennedy Gyau Boahen2,3, Charity Wiafe Akenten2,3, Yaw Adu-Sarkodie5, Ellis Owusu-Dabo3,6, Jürgen May1,2.
Abstract
Background: The epidemiology of pediatric febrile illness is shifting in sub-Saharan Africa, but malaria remains a major cause of childhood morbidity and mortality. The present study describes causes of febrile illness in hospitalized children in Ghana and aims to determine the burden of malaria coinfections and their association with parasite densities.Entities:
Mesh:
Year: 2018 PMID: 29408951 PMCID: PMC5982794 DOI: 10.1093/cid/cix1120
Source DB: PubMed Journal: Clin Infect Dis ISSN: 1058-4838 Impact factor: 9.079
Figure 1.Study profile.
Characteristics of the 1238 Febrile Study Children Admitted to the Children’s Ward
| Characteristic | No. (%) |
|---|---|
| Age, y, median (IQR) | 2 (1–4) |
| 0 | 213 (17) |
| 1 | 257 (21) |
| 2–4 | 483 (39) |
| >4 | 285 (23) |
| Female sex | 561 (45) |
| Temperature,°C, median (IQR) | 39.0 (38.5–39.6) |
| Hospital stay, d, median (IQR) | 2 (2–4) |
| Moderately malnourisheda | 95/972 (10) |
| Severely malnourishedb | 36/972 (4) |
| Severe anemiac | 37 (3) |
| Underlying condition | |
| G6PD deficiency | 44 (4) |
| Sickle cell disease | 42 (3) |
| Asthma | 7 (1) |
| Systemic inflammatory response syndrome | 689 (56) |
| Vomiting | 494 (40) |
| Cough | 311 (25) |
| Loose stool | 240 (19) |
| Skin rash | 26 (2) |
Data are presented as No. (%) unless otherwise indicated.
Abbreviations: G6PD, glucose-6-phospate dehydrogenase; IQR, interquartile range.
aModerately malnourished: ≥ –3 to < –2 standard deviations (SD) below mean of World Health Organization (WHO) z score (weight for age) in children <6 years.
bSeverely malnourished: < –3 SD below mean of WHO z score (weight for age) in children <6 years.
cHemoglobin level <5 g/dL.
Final Diagnoses and Identified Pathogens for All Hospitalized Children (N = 1238)
| Final Diagnosis and Pathogena,b,c,d | no./No. (%) |
|---|---|
|
| 728 (59) |
|
| 679/728 (93) |
| Parasite count, μL, median (IQR) | 74385 (25508–201407) |
| Parasite count, µL | |
| ≥1 to 10000 | 105/728 (14) |
| >10000 to 100000 | 313/728 (43) |
| >100000 | 310/728 (43) |
| Severe malaria | 117/1238 (9) |
| Parasite count, μL, median (IQR) | 283566 (122360–477764) |
| Cerebral malaria | 17/117 (15) |
| Lower respiratory tract infectione | 290 (23) |
|
| 209/290 (72) |
|
| 134/209 (64) |
|
| 54/209 (26) |
|
| 46/209 (22) |
|
| 42/209 (20) |
|
| 40/209 (19) |
|
| 25/209 (12) |
|
| 25/209 (12) |
| Urinary tract infection | 218 (18) |
|
| 32/218 (15) |
|
| 25/32 (78) |
|
| 7/32 (22) |
|
| 4/32 (13) |
|
| 4/32 (13) |
| Gastrointestinal infection | 210 (17) |
|
| 97/210 (40) |
|
| 32/97 (33) |
|
| 28/97 (29) |
|
| 26/97 (27) |
|
| 25/97 (26) |
|
| 21/97 (22) |
|
| 14/97 (14) |
|
| 10/97 (10) |
| Pneumonia | 120 (10) |
|
| 90/120 (75) |
|
| 58/90 (64) |
|
| 19/90 (21) |
|
| 18/90 (20) |
|
| 14/90 (16) |
|
| 14/90 (16) |
|
| 13/90 (14) |
|
| 9/90 (10) |
| Skin/soft tissue or joint/bone infectionf | 82 (7) |
| Bloodstream infection | 62 (5) |
|
| 47/62 (76) |
| Nontyphoidal | 28/62 (45) |
|
| 19/62 (31) |
|
| 6/62 (10) |
| Systemic viral disease | 58 (5) |
|
| 3/58 (5) |
|
| 7 (1) |
|
| 11 (1) |
|
| 3/11 (27) |
|
| 2/11 (18) |
| Clinical diagnosesh | 4 (0) |
|
| 2 (0) |
|
| 1 (0) |
|
| 0 (0) |
|
| 109 (9) |
Abbreviations: CNS, central nervous system; EIEC, enteroinvasive Escherichia coli; HCoV, human coronavirus; IQR, interquartile range.
aPathogens among diagnoses displayed only if frequency ≥10%.
bAccording to case definitions (see Supplementary Table 1).
cMultiple diagnoses and/or pathogens per patient possible.
dFor complete list of identified diagnoses/pathogens, see Supplementary Table 1.
eExcluding pneumonia diagnosis.
fOnly clinical diagnosis available.
gIf alanine/aspartate aminotransferase ≥150 U/L.
hMastoiditis, n = 3; mumps, n = 1.
Figure 2.Age distribution of malaria parasitemia and 6 most common diagnoses with and without pathogen detection in febrile inpatient children from Ghana. Malaria parasitemia and bloodstream infection diagnoses were defined by the presence of a pathogen. Abbreviations: CNS, central nervous system; LRTI, lower respiratory tract infection.
Figure 3.Proportion of the most common diagnoses in febrile inpatient children from Ghana, without the presence of malaria parasites and in association with 3 different parasitemia groups over increasing parasite counts. Abbreviations: CNS, central nervous system; LRTI, lower respiratory tract infection.
Characteristics of 564 Fever-Free, Nonhospitalized Children From Ghana
| Characteristic | No. (%) |
|---|---|
| Age, y, median (IQR) | 1 (0–3) |
| Female sex | 294 (52) |
| Underlying condition | |
| G6PD deficiency | 1 (0.2) |
|
| 87 (15) |
| | 82 (94) |
| Parasite count/µL, median (IQR) | 1696 (416–6360) |
| Hemoglobin level, g/dL, mean ± SD | 11.3 ± 1.2 |
| Anemia | |
| Nonsevere anemiaa | 30 (5) |
| Missing data | 35 (6) |
Data are presented as No. (%) unless otherwise indicated.
Abbreviations: G6PD, glucose-6-phospate dehydrogenase; IQR, interquartile range; SD, standard deviation.
aHemoglobin level >5.0 g/dL and <9.3 g/dL.
Figure 4.Cumulative proportions of parasitemic children along increasing parasite counts for fever-free control group, children with both parasitemia and an alternative diagnosis (coinfection), and those with parasitemia only (monoinfection). In children with Plasmodium coinfection, 17% (n = 60/356) and, in those with Plasmodium monoinfection, only 12% (n = 45/372) had a parasite count <10000/µL. At the parasite level of 100000/µL, 100% of the fever-free controls, 64% (n = 226/356) of the coinfected patients, and 54% (n = 192/372) of the monoinfected children had a parasitemia below that value.